Akums Appoints Shantanu R Chobhe as Corporate Quality Assurance Head

India's Largest Contract development and Manufacturing Organisation (CDMO), Akums Drugs & Pharmaceuticals Limited has appointed Mr. Shantanu R Chobhe as the Corporate Quality Assurance Head.

Mr. Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry. His career has spanned across several leading companies, including Lupin Ltd., Glenmark Generics Ltd., UniChem Laboratories Ltd., Wockhardt Ltd., and Cipla Ltd. Prior to joining Akums, he served as a key member of Abbott Healthcare Pvt Ltd, where he was instrumental in driving quality excellence.

At Akums, Mr. Chobhe will take charge of all quality assurance (QA) and quality control (QC) departments, overseeing both active pharmaceutical ingredients (API) and formulations. His deep expertise in quality management and regulatory affairs will be critical as Akums continues to uphold its commitment to delivering high-quality pharmaceutical products.

Mr. Chobhe holds an MSc in Analytical Chemistry from the University of Pune, India, and a PhD in Pharmacy from Preston University. He is also a member of the IP Expert Committee, the Parenteral Drug Association (PDA), and the Indian Pharmaceutical Scientists and Educators (IPSE).

Commenting on the appointment, Mr. Sandeep Jain, Managing Director of Akums Drugs & PharmaceuƟcals Limited, said, "Quality is the foundation of everything we do at Akums. We always strive to exceed industry benchmarks by elevating our standards. With Shantanu's vast experience in quality assurance, we are confident that Akums will not only uphold but also enhance our commitment to quality, ensuring our products consistently meet the highest standards of safety and efficacy."

Mr. Shantanu R Chobhe, Corporate Quality Assurance Head at Akums, added, "I am honoured to join Akums, a company that has consistently set high standards in the pharmaceutical sector. Quality is the foundation of everything we do, and I am committed to strengthening our QA and QC processes to deliver products that reflect the utmost integrity and safety. I look forward to contributing to Akums' growth journey and helping elevate India's standing on the international pharmaceutical stage."

By bringing experienced leaders like Mr. Chobhe on board, Akums is not just investing in its growth but also in the pursuit of excellence that will drive its mission to make a global impact.

Shares of Akums Drugs and Pharmaceuticals Limited was last trading in BSE at Rs. 896.40 as compared to the previous close of Rs. 853.75. The total number of shares traded during the day was 25620 in over 1284 trades.

The stock hit an intraday high of Rs. 896.40 and intraday low of 832.15. The net turnover during the day was Rs. 22133357.00.

Source : Equity Bulls

Keywords

AkumsDrugsandPharmaceuticals AKUMS INE09XN01023 Appointment CorporateQualityAssuranceHead